Seraseq ctDNA Mutation Mix v2To overcome the lack of patient like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS based ctDNA assays targeting cancer relevant somatic mutations. This specific ctDNA Mutation Mix v2 product it the